![](https://endpts.com/wp-content/uploads/2024/08/novo-nordisk-koge-site.jpg)
The site in Køge, Denmark, where Novo Nordisk Pharmatech plans to build a new API manufacturing site (Novo Nordisk)
Novo Nordisk subsidiary to build $220M API facility for chronic disease drugs
Novo Nordisk Pharmatech is building a new facility in Denmark to expand capacity for raw material production due to “significantly higher demand” from its parent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.